Outcomes of patients with borderline-resectable pancreatic cancer treated with FOLFIRINOX versus gemcitabine plus nab-paclitaxel.

被引：1

作者：

Templeton, Shaina D'Lee

Moser, Michael

Chalchal, Haji I.

Shaw, John

Luo, Yigang

Zaidi, Adnan

Ahmed, Shahid

机构：

[1] Univ Saskatchewan, Coll Med, Saskatoon, SK, Canada

[2] Univ Saskatchewan, Dept Surg, Saskatoon, SK, Canada

[3] Allan Blair Canc Ctr, Regina, SK, Canada

[4] Saskatchewan Canc Agcy, Saskatoon, SK, Canada

[5] Univ Saskatchewan, Saskatoon, SK, Canada

来源：

关键词：

D O I：

10.1200/JCO.2019.37.4_suppl.299

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

299

引用

页数：2